Ocular Therapeutix grants inducement equity awards for 86,200 shares, options priced at $10.72
OCUL•Inducement equity awards granted to new hires
Ocular Therapeutix granted inducement equity awards to nine newly hired non-executive employees under its 2019 Inducement Stock Incentive Plan.
The awards include stock options for 64,850 shares and restricted stock units for 21,350 shares; options were priced at $10.72 per share.
The options carry a 10-year term and vest over four years, with 25% vesting at year one and the remainder vesting monthly over three years.
The restricted stock units vest over three years in equal annual installments, subject to continued service.
